{"id":"W2902348661","doi":"10.1182/blood-2018-06-860015","title":"Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Carfilzomib; Hazard ratio; Renal function; Multiple myeloma; Internal medicine; Confidence interval; Urology; Creatinine; Population; Dexamethasone; Gastroenterology; Subgroup analysis; Bortezomib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001545441,0.0007399353,0.00263132,0.0004885808,0.0001970253,0.0007815203,0.0003462223,0.0006765814,0.001366677],"category_scores_gemma":[0.00169307,0.0002474418,0.005897903,0.0005570055,0.0002169628,0.0003846245,0.0003667619,0.0008561168,0.0001427203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005469793,"about_ca_system_score_gemma":0.0006734196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001205541,"about_ca_topic_score_gemma":0.003865304,"domain_scores_codex":[0.9990699,0.0004230184,0.0001234496,0.0001643911,0.0000859083,0.0001333199],"domain_scores_gemma":[0.9994266,0.000229729,0.0001407631,0.00007616152,0.0000342871,0.00009251155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6691924,0.001199634,0.1635247,0.001457062,0.07785714,0.0006331373,0.000226732,0.002457402,0.01108781,0.0002493648,0.002034289,0.07008036],"study_design_scores_gemma":[0.1900212,0.1048169,0.558941,0.0003465891,0.1165756,0.001801647,0.0009076223,0.009821485,0.005965232,0.001700518,0.008939848,0.0001623503],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925498,0.005928676,0.0001922167,0.0001919282,0.00008282677,0.0001198176,0.0004735914,0.00001253059,0.000448693],"genre_scores_gemma":[0.9984983,0.0005296516,0.0001199304,0.0001293651,0.00006984348,0.00006957496,0.000338611,0.000002828556,0.0002418216],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00263132,"threshold_uncertainty_score":0.008173168,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008370298583563177,"score_gpt":0.2423613212005972,"score_spread":0.2339910226170341,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}